PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17892128-6 2007 The proliferation and suppressive function of the CD4+ CD25+ T cells coming from tumor-bearing mice was measured by [3H]-thymidines incorporation experiment in vitro, and then effect of CD4+ CD25+ T cells originated from hepatocellular carcinoma-bearing mice on tumor growth was observed in vivo. Thymidine 121-131 CD4 antigen Mus musculus 50-53 19340309-8 2009 Taken together these results indicate an involvement of CD4(+) T-cells in J8-DT-mediated protection possibly via an ability to maintain antibody levels. Thymidine 77-79 CD4 antigen Mus musculus 56-59 19160959-5 2008 The inhibitory role of the CD4+CD25+ T cells was assessed by [3H] thymidine incorporation method and the cytokines in the cultural supernatant were detected by ELISA. Thymidine 66-75 CD4 antigen Mus musculus 27-30 20083650-4 2010 Of several founder lines, Foxp3.LuciDTR-4 mice displayed approximately 95% Treg depletion following injection of DT, resulting in activation of conventional CD4(+) T cells, probably due to lack of control by Tregs. Thymidine 36-38 CD4 antigen Mus musculus 157-160 15728482-7 2005 Stimulation with anti-CD3 mAb induced transiently greater thymidine incorporation in IL-16-deficient CD4(+) T cells than wild-type controls, but there was no difference in cell survival or in the CFSE dilution profiles. Thymidine 58-67 CD4 antigen Mus musculus 101-104 23861729-5 2013 Ovalbumin-specific CD4(+) DO11.10 and OT-II T cells that had been stimulated with their cognate antigen in the presence of OvALT-2 or OvNLT-1 displayed reduced DNA synthesis quantified by (3)H-thymidine incorporation and reduced cell division quantified by CFSE dilution. Thymidine 193-202 CD4 antigen Mus musculus 19-22